Holen Sie sich die Stockscreener-App
1.1081
1.36%
0.0081
Schlusskurs vom Vortag:
$1.10
Offen:
$1.12
24-Stunden-Volumen:
1.75M
Relative Volume:
0.62
Marktkapitalisierung:
$325.54M
Einnahmen:
$53.43M
Nettoeinkommen (Verlust:
$-52.49M
KGV:
-3.0875
EPS:
-0.3589
Netto-Cashflow:
$-58.29M
1W Leistung:
+7.21%
1M Leistung:
-23.63%
6M Leistung:
-52.15%
1J Leistung:
+48.96%
1-Tages-Spanne:
$1.10
$1.15
1-Wochen-Bereich:
$1.02
$1.18
52-Wochen-Spanne:
$0.483
$3.0699
Invivyd Inc Stock (IVVD) Company Profile
Firmenname
Invivyd Inc
Sektor
Branche
Telefon
(781) 819-0080
Adresse
209 CHURCH STREET, NEW HAVEN
Compare IVVD vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IVVD
Invivyd Inc
|
1.105 | 324.07M | 53.43M | -52.49M | -58.29M | -0.3589 |
VRTX
Vertex Pharmaceuticals Inc
|
436.69 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.59 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
806.19 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
294.62 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.32 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Invivyd Inc Stock (IVVD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-22 | Eingeleitet | BTIG Research | Buy |
| 2025-11-25 | Herabstufung | D. Boral Capital | Buy → Hold |
| 2025-10-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-04-05 | Hochstufung | Guggenheim | Neutral → Buy |
| 2024-03-26 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-19 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2023-05-01 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Invivyd Inc Aktie (IVVD) Neueste Nachrichten
Invivyd Q1 2026 earnings preview - MSN
Invivyd to Host First Quarter 2026 Financial Results and Corporate Update Call on May 14, 2026 - 富途牛牛
Invivyd (IVVD) director Ajay Royan receives stock options for 50,000 shares - Stock Titan
Invivyd (IVVD) director receives grant of 50,000 stock options at $1.04 - Stock Titan
Invivyd (IVVD) director Terrance McGuire granted 50,000 stock options at $1.04 - Stock Titan
Invivyd (IVVD) director receives 50,000 options at $1.04 strike price - Stock Titan
Invivyd grants options to director Paul Bolno | IVVD Insider Trading - Stock Titan
Invivyd (IVVD) director Tamsin Berry receives stock options for 50,000 shares - Stock Titan
IVVD stock tanks 19% today – but this analyst believes it has a potential upside of over 730% - MSN
H.C. Wainwright reiterates Invivyd stock rating on trial progress - Investing.com India
Invivyd Shareholders Reelect Board, Ratify PwC Auditor - TipRanks
Invivyd (IVVD) shareholders elect board and ratify PwC at 2026 meeting - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
H.C. Wainwright Maintains Invivyd(IVVD.US) With Buy Rating, Maintains Target Price $10 - Moomoo
IVVD: Directors were elected and the auditor ratified, with no additional proposals or questions - TradingView
H.C. Wainwright reiterates Invivyd stock rating on trial progress By Investing.com - Investing.com South Africa
Invivyd Inc stock (US46186M1080): focus shifts to monoclonal antibody NVD200 as company updates pipe - AD HOC NEWS
Invivyd, Inc. (IVVD) reports Q1 loss, lags revenue estimates - MSN
Invivyd Q1 earnings call highlights - MSN
IVVD Reiterated by BTIG -- Price Target Maintained at $10.00 - GuruFocus
Invivyd (IVVD): 10 Best NASDAQ Stocks Under $5 to Buy Right Now - Insider Monkey
Invivyd, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:IVVD) 2026-05-17 - Seeking Alpha
Invivyd stock (US46186M1080): antibody specialist under pressure after Q1 miss and high short intere - AD HOC NEWS
Invivyd outlines VYD2311 path as PEMGARDA grows 22% year-over-year while DECLARATION recruitment nears completion - MSN
Invivyd (IVVD) Q1 2026 Earnings Transcript - AOL.com
Invivyd Earnings Call Highlights Trial Progress, Growth - The Globe and Mail
RA Capital-backed fund holds 21.34M IVVD warrant shares (IVVD) - Stock Titan
Point72 (IVVD) reports 43,931 shares; shared voting/dispositive power - Stock Titan
Invivyd, Inc. (NASDAQ:IVVD) Q1 2026 Earnings Call Transcript - Insider Monkey
Invivyd, Inc.Common Stock (NQ: IVVD - FinancialContent
Invivyd (NASDAQ:IVVD) Issues Earnings Results - MarketBeat
Invivyd Q1 2026 Earnings Call Transcript - MarketBeat
Invivyd, Inc. Q1 2026 10-Q Report: Financial Results, Revenue, and Net Loss Overview - Minichart
IVVD Stock Tanks 19% Today – But This Analyst Believes It Has A Potential Upside Of Over 730% - Stocktwits
Invivyd Reports Q1 2026 Financial Results: PEMGARDA Revenue Up 22%, Strong Pipeline Progress, and VYD2311 Pivotal Data Expected Q3 2026 18 - Minichart
Invivyd Q1 Earnings Call Highlights - TradingView
Earnings call transcript: Invivyd Q1 2026 sees earnings miss, stock dips By Investing.com - Investing.com Australia
IVVD: VYD2311 pivotal trial advances as PEMGARDA revenue grows 22% year-over-year, supporting expansion - TradingView
Earnings call transcript: Invivyd Q1 2026 sees earnings miss, stock dips - Investing.com
Invivyd Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga
Invivyd Releases Q1 2026 Financial Results - AlphaStreet
Invivyd (NASDAQ:IVVD) Q1 Miss Sends Shares Lower as PEMGARDA Revenue Falls Short and R&D Costs Surge - ChartMill
Invivyd, Inc. (IVVD) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
Invivyd Posts Strong Q1 Results, Advances VYD2311 Programs - TipRanks
Invivyd : IVVD Q1 2026 Earnings Deck FINAL 2026513 - marketscreener.com
INVIVYD ($IVVD) Releases Q1 2026 Earnings - Quiver Quantitative
IVVD: Net loss increased to $41.4 million in Q1 2026, with cash reserves dropping to $184.2 million - TradingView
Invivyd Reports First Quarter 2026 Financial Results and Recent Business Highlights - The Manila Times
Invivyd, Inc. 1Q 2026: Revenue $13.74M, EPS $(0.13) — 10-Q Summary - TradingView
Finanzdaten der Invivyd Inc-Aktie (IVVD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Invivyd Inc-Aktie (IVVD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Allen Robert D. III | Chief Scientific Officer |
Feb 17 '26 |
Sale |
1.54 |
18,189 |
28,004 |
133,879 |
| Green Julie | Chief Human Resources Officer |
Feb 18 '26 |
Sale |
1.58 |
20,964 |
33,077 |
107,717 |
| Green Julie | Chief Human Resources Officer |
Feb 17 '26 |
Sale |
1.54 |
19,663 |
30,273 |
128,681 |
| Duke William E. | Chief Financial Officer |
Feb 18 '26 |
Sale |
1.58 |
20,964 |
33,077 |
107,717 |
| Duke William E. | Chief Financial Officer |
Feb 17 '26 |
Sale |
1.54 |
19,663 |
30,273 |
128,681 |
| Lee Timothy Edward | Chief Commercial Officer |
Feb 18 '26 |
Sale |
1.58 |
20,964 |
33,077 |
117,717 |
| Lee Timothy Edward | Chief Commercial Officer |
Feb 17 '26 |
Sale |
1.54 |
19,663 |
30,273 |
138,681 |
| Andersen Jill | Chief Legal Officer, Secretary |
Feb 18 '26 |
Sale |
1.58 |
34,939 |
55,127 |
181,736 |
| Andersen Jill | Chief Legal Officer, Secretary |
Feb 17 '26 |
Sale |
1.54 |
32,771 |
50,454 |
216,675 |
2.25%
0.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):